In this study, we reported that VitD supplementation relieved alveolar development impaired by lipopolysaccharide (LPS) by decreasing the production of inflammatory factors, such as IFN-γ, in a BPD rat model. Here, IFNG is linked to bronchopulmonary dysplasia.